3 August, 2023Sensorion completes a private placement of €35 million subscribed by leading US and European biotech investors
3 August, 2023GenSight Biologics obtains funding of €10 million from Sofinnova Partners, Invus and UPMC Enterprises
19 July, 2023Sensorion submits Clinical Trial Application for OTOF-GT, its lead gene therapy candidate, in Europe